RxSight, Inc. Proceeds from Notes Payable
RxSight, Inc. (RXST) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-02-25
- RxSight, Inc. proceeds from notes payable for the quarter ending 2024-12-31 was $0.00.
- RxSight, Inc. proceeds from notes payable for the quarter ending 2024-09-30 was $0.00.
- RxSight, Inc. proceeds from notes payable for the quarter ending 2023-12-31 was $0.00.
- RxSight, Inc. proceeds from notes payable for the quarter ending 2023-09-30 was $0.00.
- RxSight, Inc. proceeds from notes payable for fiscal 2025 was $0.00.
- RxSight, Inc. proceeds from notes payable for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- RxSight, Inc. proceeds from notes payable for fiscal 2023 was $20.00M.
- RxSight, Inc. proceeds from notes payable for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $20.00M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $20.00M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $20.00M 10-Q · filed 2024-08-05 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $10.00M derived: sum of 3 quarters · filed 2023-03-06 | $15.00M 10-K · filed 2023-03-06 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $10.00M derived: sum of 2 quarters · filed 2022-11-07 | $15.00M 10-Q · filed 2022-11-07 | $40.00M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $15.00M 10-Q · filed 2022-08-08 | $40.00M derived: sum of 3 quarters · filed 2022-08-08 | $40.00M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-05 | $30.00M derived: sum of 2 quarters · filed 2022-05-05 | $30.00M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $25.00M derived: sum of 2 quarters · filed 2022-03-08 | $25.00M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |